via The University of Nottingham
If you experience a major heart attack the damage could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival.
Experts at The University of Nottingham have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The research, published in the academic journal Advanced Materials, could forge the way for the creation of ‘stem cell factories’ – the mass production of human embryonic (pluripotent) stem cells.
The £2.3m research project, ‘Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation’, was led by Morgan Alexander, Professor of Biomedical Surfaces in the School of Pharmacy and Chris Denning, Professor of Stem Cell Biology in the School of Medicine and funded by the Engineering and Physical Sciences Research Council (EPSRC). The material could provide an off-the-shelf product for clinical use in the treatment of the heart, liver and brain.
Professor Alexander, Director of the Interface and Surface Analysis Centre, and his team have been searching for polymers on which human pluripotent stem cells can be grown and differentiated in vast numbers – billions at a time.
Professor Alexander said: “The possibilities for regenerative medicine are still being researched in the form of clinical trials. What we are doing here is paving the way for the manufacture of stem cells in large numbers when those therapies are proved to be safe and effective.”
Billions of stem cells are needed as trials move into second phase
Using a high throughput materials discovery approach the research team has found this man-made material, free from possible contamination and batch variability.
Professor Denning, whose field is in cardiac stem cell research, said: “The field of regenerative medicine has snowballed in the last five years and over the coming five years a lot more patients will be receiving stem cell treatments. Clinical trials are still in the very early stages. However, with this kind of product, if we can get it commercialised and validated by the regulators it could be helping patients in two to three years.”
Conditions of the heart, liver and brain are all under investigation as possible new stem cell treatments. People are already receiving stem cells derived eye cells for eye disorders.
These new materials have shown great promise in the laboratory. The research team now needs a commercial partner to test this lab based discovery on an industrial scale.
Read more: New material forges the way for ‘stem cell factories’
The Latest on: Stem cell treatments
[google_news title=”” keyword=”Stem cell treatments” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stem cell treatments
- How Hollywood Attorney Kenneth Kleinberg’s Kidney Crisis Fueled A Stem Cell Breakthrough That Puts Synthetic Replacement Kidneys In Sighton June 7, 2023 at 12:58 pm
EXCLUSIVE: A founding partner of Kleinberg Lange Cuddy & Carlo and a fixture in the Hollywood legal community for five decades, Kenneth Kleinberg built his practice lawyering the likes of Jack ...
- Cancer patient taking steps towards recovery after stem cell transplanton June 7, 2023 at 12:36 pm
A cancer patient who received a stem cell transplant has challenged herself to walk 10,000 steps a day for a month to raise cash and help her recover. Emily Land, 21, from Leeds, was diagnosed with ...
- Eva Mendes shares close-up dermaplaning treatment: 'Shaving my face!'on June 7, 2023 at 8:35 am
Formally, dermaplaning is "a cosmetic procedure aimed at achieving a smoother, more radiant complexion by gently scraping off the top layer of dead skin cells and fine facial hair using a sterile ...
- Developing new nanoparticle treatments for brain tumorson June 7, 2023 at 7:32 am
Northwestern Medicine investigators have developed a novel nanoparticle treatment for glioblastoma, according to a study published in Nature Communications.
- Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘clinical trial in a dish’ for Alzheimer’s diseaseon June 7, 2023 at 3:11 am
Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive ...
- Chicago Stem Cell Therapy & Pain Management Institute Reports Success with eClinicalWorks Cloud EHRon June 6, 2023 at 7:03 am
Jun 6, 2023--eClinicalWorks ®, the largest ambulatory cloud EHR, today announced that Chicago Stem Cell Therapy & Pain Management Institute t ...
- Get Back Into Sports with Dynamic Stem Cell Therapyon June 5, 2023 at 12:00 am
In Las Vegas, Dynamic Stem Cell Therapy encompasses the rapidly evolving functional medicine areas. Stem cells offer the potential to develop into different types of cells in the body such as nerve, ...
- Triggering cancer cells to become normal cells – how stem cell therapies can provide new ways to stop tumors from spreading or growing backon June 4, 2023 at 1:03 pm
Generally, normal cells grow and multiply through controlled cell division, where old and damaged cells are replaced after they die by new cells. Sometimes this process stops working, leading cells to ...
- Dual Stem Cell Treatment Targets Melanoma Brain Metastases in Miceon May 31, 2023 at 11:52 am
Engineered twin stem cell therapy activates immune system to suppress tumor growth and prolong survival in preclinical models of metastatic melanoma.
- Can stem cell therapy help ulcerative colitis?on May 25, 2023 at 5:58 am
Scientists are developing new treatments for ulcerative colitis (UC). There is ongoing scientific research into stem cell therapy for UC. Despite such developments, it remains an incurable condition.
via Bing News
